Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 111, Issue 11, Pages 2058-2066
Publisher
Springer Nature
Online
2014-10-08
DOI
10.1038/bjc.2014.508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dasatinib plus Capecitabine for Advanced Breast Cancer: Safety and Efficacy in Phase I Study CA180004
- (2013) G. Somlo et al. CLINICAL CANCER RESEARCH
- Up-and-down designs for phase I clinical trials
- (2013) Suyu Liu et al. Contemporary Clinical Trials
- Antitumor effects of Dasatinib on laryngeal squamous cell carcinoma in vivo and in vitro
- (2013) Yan Song et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
- (2013) John H. Strickler et al. INVESTIGATIONAL NEW DRUGS
- Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2–Dependent and Other Solid Tumors
- (2013) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer
- (2012) Joanne L. Blum et al. BREAST CANCER RESEARCH AND TREATMENT
- Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial
- (2012) Jorge E. Cortes et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy
- (2011) M. Campone et al. ANNALS OF ONCOLOGY
- KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib
- (2011) K. V. Gleixner et al. BLOOD
- Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
- (2011) J. E. Cortes et al. BLOOD
- Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors
- (2011) A. I. Daud et al. CLINICAL CANCER RESEARCH
- Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer
- (2011) Paolo Ceppi et al. INTERNATIONAL JOURNAL OF CANCER
- Current Status of Src Inhibitors in Solid Tumor Malignancies
- (2011) L. N. Puls et al. ONCOLOGIST
- Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
- (2010) E. L. Mayer et al. CLINICAL CANCER RESEARCH
- SKI-606 (Bosutinib) Blocks Prostate Cancer Invasion, Growth, and Metastasis In vitro and In vivo through Regulation of Genes Involved in Cancer Growth and Skeletal Metastasis
- (2010) S. A. Rabbani et al. MOLECULAR CANCER THERAPEUTICS
- Capecitabine Monotherapy is Efficient and Safe in All Line Settings in Patients with Metastatic and Advanced Breast Cancer
- (2009) M. Amari et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Dose Escalation Methods in Phase I Cancer Clinical Trials
- (2009) Christophe Le Tourneau et al. JNCI-Journal of the National Cancer Institute
- Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts
- (2009) W. A. Messersmith et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Src in breast cancer
- (2008) R. S. Finn ANNALS OF ONCOLOGY
- SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
- (2008) A. Vultur et al. MOLECULAR CANCER THERAPEUTICS
- Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
- (2008) Georgios Koukourakis et al. MOLECULES
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
- (2008) Jinyan Du et al. NATURE BIOTECHNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started